Somatostatin slows Aβ plaque deposition in aged APP NL-F/NL-F mice by blocking Aβ aggregation

Abstract The neuroendocrine peptide somatostatin (SST) has long been thought of as influencing the deposition of the amyloid β peptide (Aβ) in Alzheimer’s disease (AD). Missing have been in vivo data in a relevant Aβ amyloidosis model. Here we crossed App NL-F/NL-F mice with Sst-deficient mice to as...

Full description

Bibliographic Details
Main Authors: Declan Williams, Bei Qi Yan, Hansen Wang, Logine Negm, Christopher Sackmann, Claire Verkuyl, Vanessa Rezai-Stevens, Shehab Eid, Nimit Vediya, Christine Sato, Joel C. Watts, Holger Wille, Gerold Schmitt-Ulms
Format: Article
Language:English
Published: Nature Portfolio 2023-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-29559-z
_version_ 1811165958652297216
author Declan Williams
Bei Qi Yan
Hansen Wang
Logine Negm
Christopher Sackmann
Claire Verkuyl
Vanessa Rezai-Stevens
Shehab Eid
Nimit Vediya
Christine Sato
Joel C. Watts
Holger Wille
Gerold Schmitt-Ulms
author_facet Declan Williams
Bei Qi Yan
Hansen Wang
Logine Negm
Christopher Sackmann
Claire Verkuyl
Vanessa Rezai-Stevens
Shehab Eid
Nimit Vediya
Christine Sato
Joel C. Watts
Holger Wille
Gerold Schmitt-Ulms
author_sort Declan Williams
collection DOAJ
description Abstract The neuroendocrine peptide somatostatin (SST) has long been thought of as influencing the deposition of the amyloid β peptide (Aβ) in Alzheimer’s disease (AD). Missing have been in vivo data in a relevant Aβ amyloidosis model. Here we crossed App NL-F/NL-F mice with Sst-deficient mice to assess if and how the presence of Sst influences pathological hallmarks of Aβ amyloidosis. We found that Sst had no influence on whole brain neprilysin transcript, protein or activity levels, an observation that cannot be accounted for by a compensatory upregulation of the Sst paralog, cortistatin (Cort), that we observed in 15-month-old Sst-deficient mice. Sst-deficiency led to a subtle but significant increase in the density of cortical Aβ amyloid plaques. Follow-on western blot analyses of whole brain extracts indicated that Sst interferes with early steps of Aβ assembly that manifest in the appearance of SDS-stable smears of 55–150 kDa in Sst null brain samples. As expected, no effect of Sst on tau steady-state levels or its phosphorylation were observed. Results from this study are easier reconciled with an emerging body of data that point toward Sst affecting Aβ amyloid plaque formation through direct interference with Aβ aggregation rather than through its effects on neprilysin expression.
first_indexed 2024-04-10T15:44:36Z
format Article
id doaj.art-c75b27984a3d486f870a342af747fc07
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-10T15:44:36Z
publishDate 2023-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-c75b27984a3d486f870a342af747fc072023-02-12T12:12:24ZengNature PortfolioScientific Reports2045-23222023-02-0113111610.1038/s41598-023-29559-zSomatostatin slows Aβ plaque deposition in aged APP NL-F/NL-F mice by blocking Aβ aggregationDeclan Williams0Bei Qi Yan1Hansen Wang2Logine Negm3Christopher Sackmann4Claire Verkuyl5Vanessa Rezai-Stevens6Shehab Eid7Nimit Vediya8Christine Sato9Joel C. Watts10Holger Wille11Gerold Schmitt-Ulms12Tanz Centre for Research in Neurodegenerative Diseases, University of TorontoTanz Centre for Research in Neurodegenerative Diseases, University of TorontoTanz Centre for Research in Neurodegenerative Diseases, University of TorontoTanz Centre for Research in Neurodegenerative Diseases, University of TorontoTanz Centre for Research in Neurodegenerative Diseases, University of TorontoTanz Centre for Research in Neurodegenerative Diseases, University of TorontoTanz Centre for Research in Neurodegenerative Diseases, University of TorontoTanz Centre for Research in Neurodegenerative Diseases, University of TorontoTanz Centre for Research in Neurodegenerative Diseases, University of TorontoTanz Centre for Research in Neurodegenerative Diseases, University of TorontoTanz Centre for Research in Neurodegenerative Diseases, University of TorontoCentre for Prions and Protein Folding Diseases, University of AlbertaTanz Centre for Research in Neurodegenerative Diseases, University of TorontoAbstract The neuroendocrine peptide somatostatin (SST) has long been thought of as influencing the deposition of the amyloid β peptide (Aβ) in Alzheimer’s disease (AD). Missing have been in vivo data in a relevant Aβ amyloidosis model. Here we crossed App NL-F/NL-F mice with Sst-deficient mice to assess if and how the presence of Sst influences pathological hallmarks of Aβ amyloidosis. We found that Sst had no influence on whole brain neprilysin transcript, protein or activity levels, an observation that cannot be accounted for by a compensatory upregulation of the Sst paralog, cortistatin (Cort), that we observed in 15-month-old Sst-deficient mice. Sst-deficiency led to a subtle but significant increase in the density of cortical Aβ amyloid plaques. Follow-on western blot analyses of whole brain extracts indicated that Sst interferes with early steps of Aβ assembly that manifest in the appearance of SDS-stable smears of 55–150 kDa in Sst null brain samples. As expected, no effect of Sst on tau steady-state levels or its phosphorylation were observed. Results from this study are easier reconciled with an emerging body of data that point toward Sst affecting Aβ amyloid plaque formation through direct interference with Aβ aggregation rather than through its effects on neprilysin expression.https://doi.org/10.1038/s41598-023-29559-z
spellingShingle Declan Williams
Bei Qi Yan
Hansen Wang
Logine Negm
Christopher Sackmann
Claire Verkuyl
Vanessa Rezai-Stevens
Shehab Eid
Nimit Vediya
Christine Sato
Joel C. Watts
Holger Wille
Gerold Schmitt-Ulms
Somatostatin slows Aβ plaque deposition in aged APP NL-F/NL-F mice by blocking Aβ aggregation
Scientific Reports
title Somatostatin slows Aβ plaque deposition in aged APP NL-F/NL-F mice by blocking Aβ aggregation
title_full Somatostatin slows Aβ plaque deposition in aged APP NL-F/NL-F mice by blocking Aβ aggregation
title_fullStr Somatostatin slows Aβ plaque deposition in aged APP NL-F/NL-F mice by blocking Aβ aggregation
title_full_unstemmed Somatostatin slows Aβ plaque deposition in aged APP NL-F/NL-F mice by blocking Aβ aggregation
title_short Somatostatin slows Aβ plaque deposition in aged APP NL-F/NL-F mice by blocking Aβ aggregation
title_sort somatostatin slows aβ plaque deposition in aged app nl f nl f mice by blocking aβ aggregation
url https://doi.org/10.1038/s41598-023-29559-z
work_keys_str_mv AT declanwilliams somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation
AT beiqiyan somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation
AT hansenwang somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation
AT loginenegm somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation
AT christophersackmann somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation
AT claireverkuyl somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation
AT vanessarezaistevens somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation
AT shehabeid somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation
AT nimitvediya somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation
AT christinesato somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation
AT joelcwatts somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation
AT holgerwille somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation
AT geroldschmittulms somatostatinslowsabplaquedepositioninagedappnlfnlfmicebyblockingabaggregation